Skip to main content
40% Launch offerEnds 31 Dec 2026See plans
Jupiter Endovascular logo

Jupiter Endovascular

Healthcare & HealthTech
WebsiteLinkedIn

Jupiter Endovascular develops a new class of endovascular interventions based on its proprietary Transforming Fixation (TFX) technology. Its first focus is pulmonary embolism.

Open roles
1
Company size
1 - 50 employees
Headquarters
155 Jefferson Dr, Suite 100, Menlo Park, CA 94025

Follow Jupiter Endovascular

Create an exact-company alert for on-site matches and optional daily email.

Open roles